• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health's Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization

    12/5/24 11:54:12 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced that its Independent Medical Expert Consulting Services (IMEDECS) division has earned URAC accreditation as an Independent Review Organization (IRO), marking 24 years of full accreditation. This latest accreditation, for the 6.0: Comprehensive Review standards, demonstrates that IMEDECS has the policies, procedures, and structure needed to deliver fair and impartial peer-reviewed medical determinations that help its clients improve health outcomes and operational efficiency.

    URAC is the nation's leading independent accrediting organization committed to promoting health care quality and patient safety through its accreditation and certification programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts.

    "We value the trust our clients place in Acentra Health's IMEDECS team to provide unbiased medical determinations, which are grounded in evidence-based practices and a deep knowledge of the medical literature, patients' rights, and emerging technologies," said Todd Stottlemyer, CEO, Acentra Health. "URAC's accreditation affirms our commitment to providing our clients with health services and solutions that improve outcomes with maximum value and impact."

    IMEDECS works in all 50 states providing services that include medical appeals review and independent dispute resolution. Its diverse base of 600 clients includes federal and state agencies, commercial health plans, and individual organizations. With an experienced panel of over 500 medical specialists, IMEDECS processes over 45,000 internal and external appeals per year. Each case is matched by specialty to an actively practicing board-certified physician to ensure accurate and informed medical determinations. Its web-based portal provides secure 24/7 access and has earned HITRUST's certified status for information security, underscoring Acentra Health's commitment to data privacy and cybersecurity.

    Key services offered by IMEDECS include:

    • Medical Necessity Reviews
    • Coverage Determination Reviews
    • Experimental/Investigational Review
    • Quality Review
    • DRG/Coding/Pre-Pay Review
    • Coverage Policy Evaluations

    "Acentra Health's IMEDECS has been a recognized leader for providing high quality reviews since 1999," said Meghan Harris, President and Chief Operations Officer, Acentra Health. "Maintaining URAC accreditation for over two decades is a testament to the deep expertise of the team, many of whom have been with IMEDECS since its founding."

    "URAC's Independent Review Organization Accreditation validates that third-party organizations providing medical determinations are committed to a fair and impartial peer review process for all parties, including patients and physicians," said URAC's President and CEO Shawn Griffin, MD. "We are proud to recognize Acentra Health for maintaining high standards in the areas of credentialing reviewers, review timelines, and decision notification."

    URAC recognized Acentra Health's Keystone Peer Review Organization, LLC D/B/A IMEDECS at its Harrisburg, PA, location for the Independent Review Organization Accreditation. Keystone Peer Review Organization merged with CNSI and rebranded as Acentra Health in 2023. Acentra Health also holds URAC accreditations in Case Management, for its excellence in care coordination; Disease Management, for effective prevention, detection, and intervention of chronic diseases; and in Health Utilization Management, for ensuring individuals receive appropriate quality and cost-effective care in the right setting.

    IMEDECS' URAC accreditation is valid through June 1, 2027.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused service models for care management and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com.

    About URAC

    Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company's portfolio of accreditation and certification programs spans the health care industry, addressing health care management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. urac.org.

    Media Contact:

    Janice Moore

    Vice President, Corporate Communications

    703-214-3552



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What recent accreditation has Acentra Health's IMEDECS division received?

      Acentra Health's IMEDECS division earned URAC accreditation for 6.0: Comprehensive Review standards, confirming its capability to provide fair and impartial peer-reviewed medical determinations.

    • What is URAC and its significance in healthcare?

      URAC is the independent organization that develops evidence-based standards for health care quality and safety, promoting industry accountability and excellence through its accreditation programs.

    • What services does IMEDECS provide, and who are its clients?

      IMEDECS serves all 50 states, providing independent medical reviews and appeals for various clients, including federal agencies, health plans, and individual organizations, with a focus on improving health outcomes.

    • How long has Acentra Health's IMEDECS been accredited and what does this signify about its operations?

      Acentra Health's IMEDECS has been recognized for over two decades for its quality medical reviews and maintains a commitment to evidence-based practices in its operations.

    • Who backs Acentra Health financially and how does this influence its operations?

      Acentra Health is backed by Carlyle Group, a global investment firm, providing a robust financial foundation for its healthcare technology and solutions.

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 19, 2026, for its second quarter of 2026. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 20, 2026, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f

    4/20/26 4:01:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2026

    NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 12:00 p.m. (Eastern Time) on Monday, May 11, 2026 to announce its financial results for the first quarter ended March 31, 2026. The Company will report its quarterly financial results on Monday, May 11, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development compan

    4/15/26 4:25:37 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    YipitData Appoints ZoomInfo Founder and CEO Henry Schuck to Board of Directors to Support Next Phase of Growth

    Schuck brings deep expertise in scaling data-driven technology platforms and building category-defining companies YipitData, the leading provider of alternative data-driven market intelligence for institutional investors, retailers, consumer brands, and enterprises, today announced that Henry Schuck, Founder and Chief Executive Officer of ZoomInfo (NASDAQ:GTM), has joined its Board of Directors. Schuck brings more than two decades of experience building and scaling data-driven technology platforms. He founded ZoomInfo in 2007 and led its transformation from an early-stage startup into a category-defining B2B intelligence platform, culminating in a successful public listing. Under his le

    4/13/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rubenstein David M.

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    3/20/26 5:34:13 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/12/26 4:30:20 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. converted options into 9,297,883 shares and disposed of 9,297,883 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/6/26 7:02:25 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

    SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

    3/26/26 4:44:46 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    YipitData Appoints ZoomInfo Founder and CEO Henry Schuck to Board of Directors to Support Next Phase of Growth

    Schuck brings deep expertise in scaling data-driven technology platforms and building category-defining companies YipitData, the leading provider of alternative data-driven market intelligence for institutional investors, retailers, consumer brands, and enterprises, today announced that Henry Schuck, Founder and Chief Executive Officer of ZoomInfo (NASDAQ:GTM), has joined its Board of Directors. Schuck brings more than two decades of experience building and scaling data-driven technology platforms. He founded ZoomInfo in 2007 and led its transformation from an early-stage startup into a category-defining B2B intelligence platform, culminating in a successful public listing. Under his le

    4/13/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 19, 2026, for its second quarter of 2026. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 20, 2026, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f

    4/20/26 4:01:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2026

    NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 12:00 p.m. (Eastern Time) on Monday, May 11, 2026 to announce its financial results for the first quarter ended March 31, 2026. The Company will report its quarterly financial results on Monday, May 11, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development compan

    4/15/26 4:25:37 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle to Announce First Quarter 2026 Financial Results and Host Investor Conference Call

    WASHINGTON and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ:CG) announced today that it will release financial results for the first quarter 2026 on Thursday, May 7, 2026, and host a conference call at 8:30 a.m. EDT. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion. Chief Executive Officer Harvey Schwartz, along with Chief Financial Officer Justin Plouffe and Head of Public Investor Relations Daniel Harris, will review the results during the call. The earnings release will be available through all Carlyle channels, including the

    4/9/26 10:05:31 AM ET
    $CG
    Investment Managers
    Finance